Nurse Practitioner, Family · Houston, TX
NPI
1093067795
Since 2012
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
6560 Fannin St, Ste 1260
Houston, TX, 77030
Phone (713) 412-9040
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,974
23 services
Medicare patients, 2024
23
Average age 78
Drug cost, 2024
$2.9M
1,037 prescriptions
Company payments, 2025
$593
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Margaret W Nesmith was code 99214 (office e&m - established), 15 times for 15 patients. In total Margaret W Nesmith billed 23 services in 6 codes, and Medicare paid $1,974.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-11-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 15 | 15 | $79.23 | $1,188 |
Medicare prescription drug claims, 2024
In 2024, the drug Margaret W Nesmith prescribed most often to Medicare patients was Eliquis (Apixaban), with 199 prescriptions and refills. In total Margaret W Nesmith wrote 1,037 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 199 | 307 | 42 | $173K |
| Xarelto Rivaroxaban | 116 | 194 | 28 | $110K |
| Jakafi Ruxolitinib Phosphate | 59 | 59 | Under 11 | $887K |
| Valacyclovir Valacyclovir Hcl | 40 | 114 | 15 | $1,283 |
| Hydroxyurea Generic | 33 | 81 | Under 11 | $1,749 |
| Venclexta Venetoclax | 28 | 28 | Under 11 | $379K |
| Levothyroxine Sodium Generic | 27 | 65 | Under 11 | $364 |
| Prednisone Generic | 22 | 22 | Under 11 | $73.95 |
| Besremi Ropeginterferon Alfa-2b-Njft | 22 | 22 | Under 11 | $313K |
| Tramadol Hcl Generic | 21 | 23 | Under 11 | $131 |
| Pentoxifylline Generic | 19 | 45 | Under 11 | $813 |
| Warfarin Sodium Generic | 18 | 50 | Under 11 | $166 |
| Potassium Chloride Generic | 18 | 31 | Under 11 | $288 |
| Citalopram Hbr Citalopram Hydrobromide | 17 | 27 | Under 11 | $92.92 |
| Zarxio Filgrastim-Sndz | 16 | 18 | Under 11 | $19K |
Brand drugs: 548 claims; generic drugs: 489 claims; opioid claims: 21.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Margaret W Nesmith $593 ($593 in general payments such as food, travel and fees) from 13 companies. The largest payer was Incyte Corporation with $137.
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation INCY | 7 | $137 |
| Genzyme Corporation SNY | 2 | $64.31 |
| Celgene Corporation BMY | 2 | $59.17 |
| Sobi, Inc SOBI.ST | 2 | $55.9 |
| Pfizer Inc. PFE | 3 | $48.64 |
| GlaxoSmithKline, LLC. GSK | 2 | $45.6 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $33.81 |
| Agios Pharmaceuticals, Inc. AGIO | 1 | $33.68 |
| Blueprint Medicines Corporation SNY | 1 | $30.27 |
| Rigel Pharmaceuticals, Inc. RIGL | 1 | $25.81 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.